Progression-Free Survival Analysis With a Graphical Estimand Approach in the Phase 2 SAMCO-PRODIGE 54 Trial-Reply

JAMA Oncol. 2024 Apr 1;10(4):540-541. doi: 10.1001/jamaoncol.2024.0005.
No abstract available

Publication types

  • Clinical Trial, Phase II

MeSH terms

  • Humans
  • Progression-Free Survival
  • Research Design*